Allergy Service, University Hospital of Salamanca, Spain.
IBSAL (Instituto Biosanitario de Salamanca), Salamanca, Spain.
Allergy. 2016 Dec;71(12):1787-1790. doi: 10.1111/all.13032. Epub 2016 Sep 30.
European Network on Drug Allergy (ENDA) has proposed an algorithm for diagnosing immediate beta-lactam (BL) allergy. We evaluated its performance in real life. During 1994-2014, 1779 patients with suspected immediate reactions to BL were evaluated following ENDA's short diagnostic algorithm. Five hundred and nine patients (28.6%) were diagnosed of BL hypersensitivity. Of them, 457 (25.7%) were at first evaluation [403 by skin tests (ST), 12 by positive IgE and 42 by controlled provocation tests (CPT)]. At second evaluation (SE), 52 additional patients (10.2% of allergic patients) were diagnosed, [50 (2.8%) by ST and 2 (0.1%) by CPT]. Time between reaction and study was significantly longer in patients diagnosed at SE (median 5 vs 42 months; IQR 34 vs 170; P < 0.0001). Anaphylaxis was significantly associated with a diagnosis at SE. European Network on Drug Allergy/EAACI protocol was appropriate and safe when evaluating BL immediate reactions. Re-evaluation should be performed, particularly when anaphylaxis and long interval to diagnosis are present.
欧洲药物过敏网络(ENDA)提出了一种用于诊断即刻型β-内酰胺(BL)过敏的算法。我们在实际中评估了它的性能。1994 年至 2014 年间,按照 ENDA 的短诊断算法,对 1779 例疑似 BL 即刻型反应的患者进行了评估。509 例(28.6%)被诊断为 BL 过敏。其中,457 例(25.7%)为首次评估[403 例进行了皮肤试验(ST),12 例 IgE 阳性,42 例进行了控制激发试验(CPT)]。在二次评估(SE)中,又诊断出 52 例(过敏患者的 10.2%)[50 例进行了 ST,2 例进行了 CPT]。在 SE 诊断的患者中,从反应到研究的时间明显较长(中位数为 5 个月与 42 个月;IQR 34 个月与 170 个月;P < 0.0001)。过敏反应与 SE 诊断显著相关。评估 BL 即刻反应时,使用欧洲药物过敏网络/EAACI 方案是合适且安全的。特别是在发生过敏反应和诊断间隔时间较长的情况下,应进行重新评估。